Physician profile
Katherine Thomas
NPI 1982263117
$3,016.23
in general payments reported to CMS, 2019-2025
7 companies · $390 in 2025
The $390 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $252 · 2020: $13.94 · 2021: $192 · 2022: $1,645 · 2023: $118 · 2024: $406 · 2025: $390.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $913.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $913.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,509.81 | 2021-2025 | Total30, Dailies Total1, Precision 1 |
| Novartis Pharmaceuticals Corporation | $174.64 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $120.37 | 2025 | Xdemvy |
| Coopervision INC. | $97.89 | 2020-2025 | Clariti Contact Lens, Myday Contact Lens, Misight Contact Lens |
| Sight Sciences, INC. | $77.44 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $18.16 | 2025 | Cobenfy |
| Allergan, INC. | $17.92 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.